With a market capitalization (market cap) of $1.31B — a measure of how much the company is worth — Picard Medical, Inc. ranks #2,313 among the 2,502 companies tracked, and 314th in Healthcare as of October 17, 2026. Shares trade at $12.75, up 27.50% on the day.
of 2,502 tracked
Market-cap change uses historical capitalization records. Share-price returns are a different series — they can diverge when the share count changes. Those returns are not a CAGR until you pick a start value, an ending value, and years. CAGR calculator. Market cap vs. stock price.
Year-end values and the chart both come from historical market-cap records, not from applying today's share count to past prices. Latest historical observation October 16, 2026. Ranking headline cap is the snapshot figure as of October 17, 2026.
| Year | As of | Market cap | Annual change | Year-end close |
|---|---|---|---|---|
| 2026 | Oct 16, 2026 | $23.66M | -81.84% | $12.75 |
| 2025 | Dec 31, 2025 | $130.27M | — | $87.50 |
Last observation of each calendar year from historical market-cap records. The current year is through the latest date, not a completed year-end. Share-price close is the matching session for context — we do not rebuild cap from today's share count.
Ranking figure $1.31B as of October 17, 2026.
Picard Medical, Inc.'s ranking market cap is the provider-reported capitalization on the same snapshot as the rest of this site, with a share price of $12.75 as of October 16, 2026. Charts and the year-end table use a separate historical market-cap series, last observed at $23.66M on October 16, 2026. See how the ranking works.
The ranking snapshot ($1.31B as of October 17, 2026) is FMP company-screener market cap. The historical observation ($23.66M on October 16, 2026) is FMP historical-market-capitalization for the same ticker. The live quote market cap agrees with the ranking snapshot. This page does not replace one series with the other.
Live shares outstanding are not on the quote used for price, so this page does not invent a current share count. Shares outstanding vs. float.
The latest annual report (FY 2025) used a weighted-average 1,474,200 shares. That figure is an average for the year, not the live count in the market-cap formula.
Multiplying the latest price by those FY 2025 weighted-average shares would give about $18.8M. The ranking uses the provider's reported market cap instead, which reflects a current share count rather than that annual average.
Book equity: assets minus liabilities on the latest annual report.
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
Not in this snapshot
FY 2025 net worth
Largest U.S.-listed names in the same FMP sector — not a hand-picked competitor set.
| Rank | Company | Market cap | 1D |
|---|---|---|---|
| #11 | Eli Lilly and Company LLY | $1.18T | +0.43% |
| #21 | Johnson & Johnson JNJ | $615.87B | +0.90% |
| #23 |
Picard Medical, Inc., through its associated companies, is dedicated to the entire process of medical device commercialization, from initial design and manufacturing to production, distribution, marketing, and sales. A key product in its portfolio is the SynCardia TAH, a sophisticated total artificial heart specifically engineered to supplant a failing human heart in individuals afflicted with advanced cardiac disease. The firm's market presence extends across the United States, Europe, and other international regions.
Summary from the company profile (Financial Modeling Prep). Principal financial figures above are for FY 2025.
Visit websiteAs of October 17, 2026, Picard Medical, Inc. (PMI) is worth $1.31B — that is its market capitalization, the total value of its outstanding shares on MarketCapLens.
A company’s net worth is its shareholders’ equity: assets minus liabilities on the balance sheet. That is book equity, not market cap. For FY 2025, Picard Medical, Inc.’s book equity is about $3.79M. Market cap is the market value of the outstanding shares. As of October 17, 2026, its market cap is $1.31B. Book equity is an accounting remainder; market cap is a trading value. Neither is a person’s net worth.
Picard Medical, Inc. ranks #2,313 among the 2,502 companies tracked on MarketCapLens. In Healthcare it ranks #314 of 353.
Fundamentals are annual. Figures labeled with their fiscal year. Live ratios use the current price against those annual earnings.
Too little price history
Not in this snapshot
FY 2025
| $504.37B |
| +0.71% |
| #32 | UnitedHealth Group Incorporated UNH | $360.32B | -1.29% |
| #33 | Merck & Co., Inc. MRK | $360.12B | +0.53% |
| #45 | Novartis AG NVS | $286.29B | +0.16% |
Companies immediately above and below in the overall ranking. They may be in a different sector.
| Rank | Company | Market cap | 1D |
|---|---|---|---|
| #2310 | Navigator Holdings Ltd. NVGS | $1.31B | -2.69% |
| #2311 | Universal Insurance Holdings, Inc. UVE | $1.31B | +0.60% |
| #2312 | Forestar Group Inc. FOR | $1.31B | -0.08% |
| #2314 | Arlo Technologies, Inc. ARLO | $1.31B | -2.25% |
| #2315 | NextNav Inc. NN | $1.31B | -10.46% |
| #2316 | American Assets Trust, Inc. AAT | $1.31B | -0.79% |
Picard Medical, Inc.’s ranking market cap of $1.31B comes from the same snapshot as the rest of this site, as of October 17, 2026. It is not share price multiplied by the FY 2025 weighted-average share count of 1,474,200. The ranking snapshot ($1.31B as of October 17, 2026) is FMP company-screener market cap. The historical observation ($23.66M on October 16, 2026) is FMP historical-market-capitalization for the same ticker. The live quote market cap agrees with the ranking snapshot. This page does not replace one series with the other.
Over the past year, Picard Medical, Inc.’s market cap is down 96.88%, using historical market-cap records rather than today’s share count applied to past prices.
Picard Medical, Inc. (PMI) shares trade at $12.75, up 27.50% on the day, as of October 17, 2026.
Live P/E is share price divided by annual earnings per share. It is blank when earnings are missing, zero, or negative — not a 0× multiple.